Free Trial
NYSE:ALC

Alcon (ALC) Stock Price, News & Analysis

$93.37
+1.53 (+1.67%)
(As of 07/26/2024 ET)
Today's Range
$92.99
$94.22
50-Day Range
$87.37
$93.37
52-Week Range
$69.44
$94.22
Volume
1.16 million shs
Average Volume
873,554 shs
Market Capitalization
$46.05 billion
P/E Ratio
44.25
Dividend Yield
0.28%
Price Target
$96.71

Alcon MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
3.6% Upside
$96.71 Price Target
Short Interest
Bearish
0.77% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.08mentions of Alcon in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
14.43%
From $3.05 to $3.49 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.17 out of 5 stars

Medical Sector

603rd out of 936 stocks

Ophthalmic Goods Industry

6th out of 7 stocks

ALC stock logo

About Alcon Stock (NYSE:ALC)

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

ALC Stock Price History

ALC Stock News Headlines

Rare signal predicts 50% market drop - before election
The market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED will cut rates any day now. But there's one indicator that's flashing a BIG warning sign to investors.
Rare signal predicts 50% market drop - before election
The market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED will cut rates any day now. But there's one indicator that's flashing a BIG warning sign to investors.
Here's what to expect from Alcon's earnings
See More Headlines
Receive ALC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alcon and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/13/2024
Ex-Dividend for 5/16 Dividend
5/14/2024
Dividend Payable
5/16/2024
Today
7/26/2024
Next Earnings (Confirmed)
8/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Ophthalmic goods
Sub-Industry
Health Care Facilities
CUSIP
04544X30
Employees
25,000
Year Founded
1945

Price Target and Rating

Average Stock Price Target
$96.71
High Stock Price Target
$105.00
Low Stock Price Target
$85.00
Potential Upside/Downside
+3.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
16 Analysts

Profitability

Net Income
$974 million
Pretax Margin
9.98%

Debt

Sales & Book Value

Annual Sales
$9.46 billion
Cash Flow
$5.31 per share
Book Value
$41.81 per share

Miscellaneous

Free Float
485,605,000
Market Cap
$46.17 billion
Optionable
Optionable
Beta
0.97

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. F. Michael Ball (Age 69)
    Executive Chairman
    Comp: $1.17M
  • Mr. Arthur B. Cummings M.D. (Age 62)
    Executive Director
    Comp: $284.68k
  • Mr. David J. Endicott (Age 59)
    CEO & Director
    Comp: $4.82M
  • Mr. Timothy C. Stonesifer (Age 57)
    Chief Financial Officer
  • Margaret Buckley
    Chief Accounting Officer
  • Dr. Franck Leveiller
    Senior VP, Head of Global R&D and Chief Scientific Officer
  • Ms. Sue-Jean Lin (Age 65)
    Senior VP and Chief Information & Transformation Officer
  • Mr. Royce R. Bedward (Age 58)
    Senior VP, General Counsel & Corporate Secretary
  • Ms. Kimberly Martin (Age 49)
    Senior VP, Chief HR Officer & Corporate Communications
  • Mr. Laurent Attias (Age 56)
    Head of Corporate Development, Strategy, BD&L and M&A

Should I Buy Alcon Stock? ALC Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Alcon Inc.:

  • Alcon Inc. has shown a positive Fifty-Two Week Performance of 11.11%, indicating potential growth.
  • The Days to Cover ratio of 5.2 suggests a relatively low short interest, reducing the risk of a short squeeze.
  • Institutional Ownership Percentage of 60.3% indicates confidence from larger investors in the company's future.
  • Alcon Inc.'s Average Daily Volume of 815,800 shares provides liquidity for investors looking to buy or sell.
  • The current stock price of $80.05 (as of 01/15/2024) may present a buying opportunity based on future growth potential.

Cons

Investors should be bearish about investing in Alcon Inc. for these reasons:

  • The Month-to-Month Change Percentage in Shares Shorted is -10.17%, indicating a recent increase in short interest which could pressure the stock price.
  • Short Percentage of Float at 0.79% suggests some investors are betting against the stock, potentially impacting its performance.
  • Alcon Inc.'s Outstanding Shares of 499,700,000 may dilute earnings per share and limit potential upside for investors.
  • The Float Size of 483,830,000 shares may lead to increased volatility in the stock price due to a larger supply available for trading.
  • The record date of 01/15/2024 may have already factored in certain market expectations, potentially limiting short-term gains.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, July 2, 2024. Please send any questions or comments about these Alcon pros and cons to contact@marketbeat.com.

ALC Stock Analysis - Frequently Asked Questions

How have ALC shares performed this year?

Alcon's stock was trading at $78.12 on January 1st, 2024. Since then, ALC shares have increased by 19.5% and is now trading at $93.37.
View the best growth stocks for 2024 here
.

How were Alcon's earnings last quarter?

Alcon Inc. (NYSE:ALC) posted its quarterly earnings results on Monday, May, 13th. The healthcare company reported $0.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.72 by $0.06. The healthcare company earned $2.46 billion during the quarter, compared to analysts' expectations of $2.46 billion. Alcon had a trailing twelve-month return on equity of 6.87% and a net margin of 10.96%.

What is Greg D. Wight's approval rating as Alcon's CEO?

6 employees have rated Alcon Chief Executive Officer Greg D. Wight on Glassdoor.com. Greg D. Wight has an approval rating of 100% among the company's employees. This puts Greg D. Wight in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Does Alcon have any subsidiaries?

The following companies are subsidiaries of Alcon: Alcon (China) Ophthalmic Product Co. Ltd., Alcon Finance Corporation, Alcon Japan Ltd., Alcon Laboratories Inc., Alcon Pharmaceuticals Ltd., Alcon Research LLC, and Alcon Vision LLC.

Who are Alcon's major shareholders?

Top institutional shareholders of Alcon include Bank of New York Mellon Corp (1.40%), AMF Tjanstepension AB (0.80%), Allspring Global Investments Holdings LLC (0.53%) and Assenagon Asset Management S.A. (0.33%).

How do I buy shares of Alcon?

Shares of ALC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Alcon own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Alcon investors own include AT&T (T), Novartis (NVS), Verizon Communications (VZ), International Business Machines (IBM), Intel (INTC), Pfizer (PFE) and Cisco Systems (CSCO).

This page (NYSE:ALC) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners